Clinical Case Reports (Feb 2022)
COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
- Takatoshi Enomoto,
- Takayuki Shiroyama,
- Haruhiko Hirata,
- Saori Amiya,
- Yuichi Adachi,
- Takayuki Niitsu,
- Yoshimi Noda,
- Reina Hara,
- Kiyoharu Fukushima,
- Yasuhiko Suga,
- Kotaro Miyake,
- Shohei Koyama,
- Kota Iwahori,
- Izumi Nagatomo,
- Natsuko Tokuhira,
- Akinori Uchiyama,
- Yoshito Takeda,
- Atsushi Kumanogoh
Affiliations
- Takatoshi Enomoto
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Takayuki Shiroyama
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Haruhiko Hirata
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Saori Amiya
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Yuichi Adachi
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Takayuki Niitsu
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Yoshimi Noda
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Reina Hara
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Kiyoharu Fukushima
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Yasuhiko Suga
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Kotaro Miyake
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Shohei Koyama
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Kota Iwahori
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Izumi Nagatomo
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Natsuko Tokuhira
- Department of Anesthesiology and Intensive Care Medicine Osaka University Graduate School of Medicine Osaka Japan
- Akinori Uchiyama
- Department of Anesthesiology and Intensive Care Medicine Osaka University Graduate School of Medicine Osaka Japan
- Yoshito Takeda
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- Atsushi Kumanogoh
- Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan
- DOI
- https://doi.org/10.1002/ccr3.5463
- Journal volume & issue
-
Vol. 10,
no. 2
pp. n/a – n/a
Abstract
Abstract This is the first report of COVID‐19 in a human T‐cell lymphotropic virus type‐1 (HTLV‐1) carrier. HTLV‐1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID‐19‐HTLV‐1 coinfection, specifically on the appropriate use of corticosteroid treatment while considering secondary infection.
Keywords
